Patent-pending Coretrak is designed for challenging fixation cases of the foot, such as those involving diabetic patients.
As a minimally invasive solution, Wright Medical Group says Coretrak can aid healing, which is important for the growing population of diabetics who are already at a high risk for surgical complications, the company stated.
Read Wright Medical Group’s release about the Coretrak.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
